Clinical Trial

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a trial to evaluate the safety and efficacy of SHR-1819 injection in the treatment of patients with seasonal allergic rhinitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-21.
Status change: Not Yet Recruiting → Recruiting 2025-09-01
Trial Details
NCT Number NCT07091357
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Seasonal Allergic Rhinitis
Enrollment 100 participants
Start Date 2025-08-06
Primary Completion 2025-10 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-03